

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total Revenue | 112.33 | 128.97 | 67.93 | 36.48 |
| Total Expenses | 81.06 | 90.81 | 54.34 | 27.81 |
| Profit Before Tax | 31.27 | 38.16 | 13.59 | 8.67 |
| Profit After Tax | 23.07 | 28.11 | 10.47 | 6.24 |
| Operating Profit After Depreciation | 33.37 | 38.77 | 14.13 | 8.87 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Fixed Assets | 95.44 | 80.84 | 20.14 | 14.50 |
| Total Non Current Assets | 114.37 | 100.73 | 21.46 | 15.53 |
| Total Current Assets | 77.58 | 70.20 | 33.82 | 25.81 |
| Total Assets | 191.94 | 170.94 | 55.28 | 41.34 |
| Total Shareholder's Fund | 145.16 | 122.10 | 42.20 | 33.82 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Net Cash From Operating Activities | 30.66 | 30.45 | 4.59 | -5.22 |
| Net Cash Used In Investing Activities | -35.48 | -33.09 | -2.91 | -0.08 |
| Net Cash Used In Financing Activities | -1.09 | 9.84 | -0.48 | -0.18 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 112.33 | 128.97 | 92.07 | 74.86 | 51.18 |
| Total Expenses | 81.03 | 90.80 | 71.84 | 56.85 | 38.23 |
| Profit Before Tax | 31.30 | 38.17 | 20.24 | 18.01 | 12.95 |
| Profit After Tax | 23.10 | 28.12 | 15.18 | 13.40 | 9.75 |
| Operating Profit After Depreciation | 33.37 | 38.77 | 20.42 | 18.15 | 13.02 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 95.44 | 80.84 | 58.27 | 27.19 | 18.85 |
| Total Non Current Assets | 114.45 | 100.82 | 75.75 | 32.11 | 22.61 |
| Total Current Assets | 77.53 | 70.13 | 62.22 | 44.91 | 37.99 |
| Total Assets | 191.98 | 170.94 | 137.97 | 77.02 | 60.60 |
| Total Shareholder's Fund | 145.19 | 122.11 | 87.20 | 61.57 | 50 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 30.66 | 30.45 | 17.10 | 13.42 | 3.31 |
| Net Cash Used In Investing Activities | -35.48 | -33.18 | -50.98 | -11.91 | -0.94 |
| Net Cash Used In Financing Activities | -1.06 | 9.85 | 38.66 | -1.09 | -0.66 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 30.32 | 24.67 | 24.43 | 27.05 | 32.33 |
| Total Expenses | 20.69 | 17.37 | 14.56 | 17.15 | 21.03 |
| Profit Before Tax | 6.72 | 4.60 | 8.77 | 7.52 | 8.63 |
| Profit After Tax | 4.96 | 3.45 | 6.59 | 5.42 | 6.41 |
| Operating Profit after Depreciation | 10.32 | 7.96 | 12.16 | 10.61 | 11.49 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 30.32 | 24.67 | 24.43 | 27.05 | 32.33 |
| Total Expenses | 20.69 | 17.37 | 14.56 | 17.15 | 21.03 |
| Profit Before Tax | 6.72 | 4.60 | 8.78 | 7.53 | 8.64 |
| Profit After Tax | 4.96 | 3.45 | 6.60 | 5.43 | 6.42 |
| Operating Profit after Depreciation | 10.32 | 7.96 | 12.16 | 10.61 | 11.49 |
₹0.5/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
| Fund Name | AUM |
|---|---|
| Bandhan BSE Healthcare Index Fund | 0.01% |
On 7 November 2025
04 Nov 2025, 03:23 pm
On 9 September 2025
19 Aug 2025, 11:04 am
On 1 August 2025
29 Jul 2025, 11:09 am
On 19 May 2025
12 May 2025, 10:22 am
On 5 February 2025
30 Jan 2025, 11:37 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.